C12N 2501/165
Vascular endothelial growth factor [vegf]
Official title: Vascular endothelial growth factor [VEGF]
C12N2501/165 (Vascular endothelial growth factor [vegf]) appears on 362 US grants and 868 published applications in this corpus.
Search patents in C12N- Granted patents
- 362
- Published applications
- 868
- Assignees
- 457
- Inventors
- 1,627
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 3 | 9 |
| 2003 | 5 | 11 |
| 2004 | 2 | 14 |
| 2005 | 4 | 15 |
| 2006 | 1 | 19 |
| 2007 | 5 | 9 |
| 2008 | 5 | 23 |
| 2009 | 7 | 19 |
| 2010 | 7 | 20 |
| 2011 | 7 | 15 |
| 2012 | 11 | 28 |
| 2013 | 10 | 19 |
| 2014 | 10 | 25 |
| 2015 | 13 | 35 |
| 2016 | 18 | 36 |
| 2017 | 23 | 46 |
| 2018 | 18 | 37 |
| 2019 | 16 | 39 |
| 2020 | 29 | 67 |
| 2021 | 25 | 62 |
| 2022 | 25 | 64 |
| 2023 | 20 | 69 |
| 2024 | 31 | 66 |
| 2025 | 44 | 64 |
| 2026 | 18 | 56 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Method for obtaining endothelial cells from pluripotent stem cells1 Sep 2026US 12,723,237 B2Adhara
- Methods of preconditioning vascular cells for transduction, methods of transduction and methods of preserving transduced cells4 Aug 2026US 12,698,477 B2Vessi Therapeutics Ltd
- Generating populations of human blood and blood vessel progenitors from pluripotent stem cells14 Jul 2026US 12,680,077 B2The Board of Trustees of the Leland Stanford Junior University
- Biocompatible conditioned cell medium compositions and uses thereof16 Jun 2026US 12,655,384 B2Cellum Biomedical, Inc.
- Methods and compositions related to platelet releasate and platelet-rich fibrin8 Oct 2026US 2026/0306546 A1Biobridge Global
- SIRPalpha Knockout iPSC-derived and CAR-comprising Macrophages with Enhanced Anti-tumor Activity24 Sep 2026US 2026/0284104 A1Wisconsin Alumni Research Foundation
- Generation of induced neutrophils with increased activation and transmigration capabilities10 Sep 2026US 2026/0265695 A1
- Method for isolating hemogenic endothelial cells3 Sep 2026US 2026/0258361 A1Fondazione Telethon Ets
- Process for preparation of human umbilical cord blood plasma and culture media for tissue regeneration27 Aug 2026US 2026/0250637 A1Iceta - Instituto De CiêNcias, Tecnologias E Agroambiente Da Universidade Do Porto
Most cited
By later US patents
- Embryonic cell populations and methods to isolate such populations111US 5,914,268 ANational Jewish Center for Immunology and Respiratory Medicine · 1999
- VEGF gene transfer into endothelial cells for vascular prosthesis89US 5,785,965 AThe Board of Trustees of the Leland Stanford Junior Univ. · 1998
- Method of transluminal application of myogenic cells for repair or replacement of heart tissue88US 6,805,860 B12004
- Synergistic composition for endothelial cell growth80US 5,073,492 AThe Johns Hopkins University · 1991
- Embryonic cell populations and methods to isolate such populations76US 5,874,301 ANational Jewish Center for Immunology and Respiratory Medicine · 1999